Mereo BioPharma Group plc (MREO)

NASDAQ: MREO · Real-Time Price · USD

0.3200

-0.0100 (-3.03%)

At close: Apr 2, 2026, 4:00 PM EDT

0.3296

+0.0096 (3.00%)

After-hours: Apr 2, 2026, 7:23 PM EDT

Mereo BioPharma Group Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	40.99	69.8	57.41	68.15	127.49
Cash & Short-Term Investments	40.99	69.8	57.41	68.15	127.49
Cash Growth	-41.27%	21.57%	-15.76%	-46.54%	297.32%
Other Receivables	1.5	2.79	4.5	3.23	3.01
Total Trade Receivables	1.5	2.79	4.5	3.23	3.01
Other Current Assets	2.53	2.18	1.83	3.78	3.78
Total Current Assets	45.02	74.76	63.75	75.17	134.28
Net Property, Plant & Equipment	0.38	0.98	1.65	2.22	3.42
Other Intangible Assets	0.52	0.64	14.16	24.38	33.21
Total Assets	45.92	76.39	79.56	101.77	170.91
Accounts Payable	1.33	2.44	2.65	3.72	3.38
Accrued Expenses	2.03	4.07	5.46	5.43	5.17
Current Portion of Long-Term Debt	-	5.54	-	13.41	-
Current Portion of Leases	0.2	0.71	0.65	0.56	0.84
Other Current Liabilities	0.74	1.1	1.37	1.34	7.56
Total Current Liabilities	4.3	13.85	10.14	24.47	16.96
Long-Term Debt	-	-	4.99	-	19.45
Long-Term Leases	-	0.19	0.91	1.48	2.37
Other Long-Term Liabilities	0.7	1.39	0.76	0.16	13.16
Total Long-Term Liabilities	0.7	1.57	6.65	1.63	34.98
Total Liabilities	5	15.42	16.8	26.1	51.94
Common Stock	3.14	3.06	2.68	2.27	2.37
Treasury Stock	-	-	-1.24	-1.28	-1.54
Additional Paid-in Capital	549.62	539.64	523	475.51	520.11
Accumulated Other Comprehensive Income	-10.82	-18.85	-0.41	-2.62	-0.46
Retained Earnings	-501.02	-462.88	-461.26	-398.22	-401.5
Total Common Shareholders' Equity	40.92	60.97	62.77	75.66	118.98
Shareholders' Equity	40.92	60.97	62.77	75.66	118.98
Total Liabilities & Equity	45.92	76.39	79.56	101.77	170.91
Total Debt	0.2	6.43	6.54	15.45	22.66
Net Cash (Debt)	40.79	63.37	50.87	52.7	104.83
Net Cash Growth	-35.63%	24.57%	-3.47%	-49.73%	1285.75%
Net Cash Per Share	0.26	0.43	0.39	0.44	0.94
Book Value	40.92	60.97	62.77	75.66	118.98
Book Value Per Share	0.26	0.41	0.48	0.63	1.07
Tangible Book Value	40.4	60.33	48.6	51.28	85.77
Tangible Book Value Per Share	0.25	0.41	0.37	0.43	0.77

Updated Mar 19, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q